Asciminib
Asciminib (ABL001) is a potent and selective Bcr-Abl inhibitor (Kd: 0.5–0.8nM).
| Catalog Number | T5177 |
| Alternative Name(s) | ABL001 |
| Research Area | Cytoskeletal Signaling|||Tyrosine Kinase/Adaptors|||Angiogenesis |
| Molecular Formula | C20H18ClF2N5O3 |
| CAS# | 1492952-76-7 |
| Purity | 97.93% |
| SMILES | O[C@@H]1CCN(C1)c1ncc(cc1-c1ccn[nH]1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1 |
| Size | 50 mg |
| Supplier Page | https://www.targetmol.com/compound/Asciminib |
| Additional Information | https://www.targetmol.com/datasheet/T5177 |